Articles with "plasma tau217" as a keyword



Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients

Sign Up to like & get
recommendations!
Published in 2025 at "Scientific Reports"

DOI: 10.1038/s41598-025-90232-8

Abstract: We investigated plasma phosphorylated tau217 (p-tau217) and p-tau181 efficacy in predicting positive amyloid positron emission tomography (PET) results and cognitive stage transitions. Plasma p-tau217 and p-tau181 were measured in participants who were cognitively unimpaired (CU,… read more here.

Keywords: predicting amyloid; tau217 tau181; positivity; plasma tau217 ... See more keywords
Photo by impulsq from unsplash

Plasma p-tau217: from ‘new kid’ to most promising candidate for Alzheimer’s disease blood test

Sign Up to like & get
recommendations!
Published in 2020 at "Brain"

DOI: 10.1093/brain/awaa329

Abstract: This scientific commentary refers to ‘Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease’, by Mattsson-Carlgren et al. (doi:10.1093/brain/awaa286). read more here.

Keywords: plasma tau217; tau217 new; new kid; alzheimer disease ... See more keywords

Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison

Sign Up to like & get
recommendations!
Published in 2024 at "Brain"

DOI: 10.1093/brain/awae368

Abstract: Abstract Plasma phosphorylated-tau217 (p-tau217) has been shown to be one of the most accurate diagnostic markers for Alzheimer’s disease. No studies have compared the clinical performance of p-tau217 as assessed by the fully automated Lumipulse… read more here.

Keywords: alzheimer disease; simoa; alzpath; tau217 ... See more keywords

Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease

Sign Up to like & get
recommendations!
Published in 2025 at "Neurology"

DOI: 10.1212/wnl.0000000000213954

Abstract: Background and Objectives Identifying β-amyloid (Aβ) positivity is crucial for selecting candidates for Aβ-targeted therapies in early-stage Alzheimer disease (AD). While Aβ PET is accurate, its high cost limits routine use. Plasma p-tau217 testing offers… read more here.

Keywords: road; early stage; risk; plasma tau217 ... See more keywords

Semantic intrusion errors differentiate between amnestic MCI who are plasma p-tau217+ from p-tau217- after adjusting for initial learning strength

Sign Up to like & get
recommendations!
Published in 2025 at "Frontiers in Neurology"

DOI: 10.3389/fneur.2025.1613694

Abstract: Background Semantic intrusion errors (SIEs) are associated with mild cognitive impairment (MCI) due to Alzheimer's disease (AD). It is unknown whether accounting for maximum learning capacity still leads to an increase in SIEs when elevated… read more here.

Keywords: amnestic mci; tau217; plasma tau217; intrusion errors ... See more keywords

Performance of Plasma Phosphorylated tau-217 in Patients on the Continuum of Alzheimer’s Disease

Sign Up to like & get
recommendations!
Published in 2025 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms26146771

Abstract: Recent studies have demonstrated the high analytical and diagnostic performance of plasma p-tau217 using well-defined cohorts. We aimed to assess the analytical, diagnostic, and prognostic utility of plasma p-tau217 as a routine biomarker in symptomatic… read more here.

Keywords: performance plasma; plasma; alzheimer disease; plasma tau217 ... See more keywords